Review Article

Pathophysiologic Mechanisms of Insulin Secretion and Signaling-Related Genes in Etiology of Polycystic Ovary Syndrome

Table 1

Candidate genes involved in etiology of polycystic ovary syndrome related to insulin resistance and type 2 diabetes mellitus.

GeneGenetic marker(s)Type of studyPhysiologic functionStudied populationType of polymorphismReferences

ADIPOQ, RETNSNPs at position −420 of the RETN and/or −11377 of the ADIPOQCase-controlInsulin resistance and obesityJapaneseRETN−420G/G[29]
ADIPOQrs1501299, rs2241766, and rs266729Case-controlInsulin resistanceJordanianG allele[31]
ADIPOQrs17300539, rs266729, rs822395, rs822396, rs2241766, rs1501299, rs2241767, rs3774261, and rs17366743Case-controlInsulin resistanceSaudi Arabianrs2241766, rs1501299, rs2241767, rs3774261, and rs17366743[35]
ADIPOQSNPsCase-controlModulating insulin sensitivityMiniaHigher genotyping distributions of TG, GG, and TT[27]
ADIPOQT45G and G276TMeta-analysisInsulin resistance, obesity, and T2DMAsianG276T[34]
ADIPOQrs1501299Case-controlLipid profilePolishGG[32]
CAPN10UCSNP-44, UCSNP-43, UCSNP-19, and UCSNP-63Case-controlCa-mediated intracellular signaling, and insulin secretionSpanishUCSNP-44[36]
CAPN10CAPN10 haplotypesHaplotype-phenotype correlationCa-mediated intracellular signaling, and insulin secretionSpanishUCSNP-44[37]
CAPN10SNPsMeta-analysis, meta-regressionCa-mediated intracellular signaling, and insulin secretionAsianUCSNP-19, UCSNP-63, and UCSNP-45[38]
CAPN10UCSNP-43, UCSNP-44, UCSNP-19, and UCSNP-63Cross-sectional population-basedCa-mediated intracellular signaling, and insulin secretionSpanishUCSNP-44, UCSNP-43, and UCSNP-19[39]
CAPN10UCSNP-43, UCSNP-19, and UCSNP-63Case-controlCa-mediated intracellular signaling, and insulin secretionChileanUCSNP-43[40]
CAPN10UCSNP-43, UCSNP-19, and UCSNP-63Cross-sectionalCa-mediated intracellular signaling, and insulin secretionBrazilianUCSNP-43[41]
CAPN10UCSNP-44, UCSNP-43, UCSNP-56, UCSNP-19, and UCSNP-63Case-controlCa-mediated intracellular signaling, and insulin secretionIndianUCSNP-44[42]
CAPN10UCSNP-43 and rs3792267Case-controlCa-mediated intracellular signaling, and insulin secretionGreekUCSNP-43[43]
CAPN10UCSNP-43 and rs3792267Case-controlCa-mediated intracellular signaling, and insulin secretionIndianND[44]
CAPN10UCSNP-19, UCSNP-63, UCSNP-44, and UCSNP-43Meta-analysisCa-mediated intracellular signaling, and insulin secretionDifferent populationsUCSNP-19 and UCSNP-63[45]
PPAR-γGly482Ser, PPAR-α Leu162Val, PPAR-δ rs2267668A/G, PPAR-δ−87T/C, PPAR-γ2 Pro12Ala, and PPAR-γ2-−681C/GCase-control, meta-analysisGlucose homeostasis, lipid metabolism, transport, and storageCaucasianGly482Ser and Pro12Ala[46]
PPAR-γPro12AlaMeta-analysesGlucose homeostasis, lipid metabolism, transport, and storageDifferent populationPro12Ala[47]
PPAR-γ2Pro12AlaCase-controlGlucose homeostasis, lipid metabolism, transport, and storageChineseND[48]
PPAR-γ2Pro12AlaCase-controlGlucose homoeostasis, lipid metabolism, and adipocyte differentiationSouth IndianPro12Ala[49]
PPAR-γPro12Ala (exon 2) and His447His (exon 6)Case-controlInsulin resistance and adipositySouthern MediterraneanPro12Ala (exon 2)[50]

Abbreviations: ADIPOQ, adiponectin; CAPN10, calpain 10; PPAR-γ, peroxisome proliferator-activated receptor-gamma; ND, no data.